Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm-Associated Myelofibrosis: A Retrospective Cohort Study.
Clinical Lymphoma Myeloma and Leukemia(2017)
摘要
Although the presence of severe comorbidities was lower when assessed by ACE-27 (13%) compared with HCT-CI (23%), and the spectrums of comorbidities captured were different, the overall impact of severe comorbidities as assessed by both scales appears to be similar and associated with a survival disadvantage.
更多查看译文
关键词
ACE-27 HCT-CI,Acute leukemia,DIPSS,Natural history,Outcomes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络